PARIS — People suffering from advanced Parkinson’s disease could benefit long-term from continuous delivery of medication through a device similar to an insulin pump, a recent French study found.
Published in Nature Partner Journals with the Parkinson’s Foundation, the real-world observational study followed 110 patients being treated at the Pitie-Salpetriere hospital in Paris.
The second most common neurodegenerative disease after Alzheimer’s, Parkinson’s is sometimes treated with the medication apomorphine to lessensymptoms such as shaking, stiffness or slowness of movement.
It helps replace the dopamine typically lacking in Parkinson’s patients, but taken orall…
Keep on reading: Medicine ‘pump’ could help Parkinson’s patients